Wesfarmers (ASX:WES) share price edges higher on sweetened API bid

Wesfarmers beefs up its bid to acquire Priceline owner, Australian Pharmaceutical Industries.

| More on:
Pharmacist in white coat holding clipboard looking at medication stock on shelf

Image source: Getty Images

The Wesfarmers Ltd (ASX: WES) share price is in the green on Thursday and currently changing hands at $56.80, up 0.26%.

This follows news that the conglomerate has sweetened its offer to acquire Australian Pharmaceutical Industries Ltd (ASX: API) today.

There’s a bit of history here, so let’s investigate further.

What went down today?

Wesfarmers revised its indicative proposal to acquire Australian Pharmaceuticals after the healthcare company rejected the original $1.38 per share proposal back in July.

Wesfarmers wants to buy 100% of the company’s outstanding shares and is offering $1.55 per share under a revised scheme arrangement.

This represents a 22% premium to the pharmaceutical company’s closing price on Wednesday. It’s also a 35% premium to its share price on 9 July when the original offer was made.

The Australian Pharmaceuticals board intends to unanimously recommend the revised proposal, which is still subject to due diligence by Wesfarmers.

The board will back the deal if no superior offers are made in the foreseeable future. The board will also seek the opinion of an independent expert, according to the release.

If everything comes back clear, it will be all systems go to get the deal done, it appears.

What’s next for the Wesfarmers share price?

The deal is still subject to a number of conditions, including satisfactory completion of due diligence.

They also need clearance from the Australian Competition and Consumer Commission (ACCC) and full backing from the API board.

Wesfarmers shareholders don’t have to do anything right now. However, the next moves will no doubt have some impact on the Wesfarmers share price.

The company has until 16 October to complete its due diligence. After that, both parties will enter into a binding offer if everything is satisfactory.

That’s a key date for shareholders of both companies to keep pencilled in.

Wesfarmers share price snapshot

The Wesfarmers share price has had a choppy year to date but has gained 9.9% since January 1.

Wesfarmers shares are up by about 25% over the past 12 months. This is in line with the return of the S&P/ASX 200 index (ASX: XJO) over the same time.

Should you invest $1,000 in Wesfarmers right now?

Before you consider Wesfarmers, you'll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Wesfarmers wasn't one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers